Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. (NUS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · NUS · as of Mar 31, 2025
Ownership Breakdown
197
Institutional Holders
▼ 7 vs Q4
$263.71M
Total Inst. Value
▲ $4.25M vs Q4
48.55M
Shares Outstanding
freeFloat 97.12%
36.33M
13F Shares Held
▼ 1.35M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
NUS largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. wholesale-drugs, proprietaries & druggists' sundries | 4.53M | 9.11% | 9.11% | $32.90B | May 2, 2025 | ▲ 30.6K |
VANGUARD GROUP INC wholesale-drugs, proprietaries & druggists' sundries | 4.13M | 8.31% | 8.31% | $30.01B | May 9, 2025 | ▲ 193.0K |
D. E. SHAW & CO., INC. wholesale-drugs, proprietaries & druggists' sundries | 2.38M | 4.79% | 4.79% | $17.30B | May 15, 2025 | ▲ 131.9K |
RENAISSANCE TECHNOLOGIES LLC wholesale-drugs, proprietaries & druggists' sundries | 1.83M | 3.68% | 3.68% | $13.31B | May 14, 2025 | ▲ 153.8K |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. wholesale-drugs, proprietaries & druggists' sundries | 1.39M | 2.80% | 2.80% | $10.12B | May 7, 2025 | ▲ 820.0K |
GOLDMAN SACHS GROUP INC wholesale-drugs, proprietaries & druggists' sundries | 1.32M | 2.65% | 2.65% | $9.58B | Jun 27, 2025 | ▲ 88.1K |
MORGAN STANLEY wholesale-drugs, proprietaries & druggists' sundries | 1.27M | 2.55% | 2.55% | $9.23B | May 15, 2025 | ▲ 36.8K |
GEODE CAPITAL MANAGEMENT, LLC wholesale-drugs, proprietaries & druggists' sundries | 1.15M | 2.32% | 2.32% | $8.38B | May 13, 2025 | ▲ 29.0K |
STATE STREET CORP wholesale-drugs, proprietaries & druggists' sundries | 1.06M | 2.13% | 2.13% | $7.69B | May 15, 2025 | ▼ 59.0K |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC wholesale-drugs, proprietaries & druggists' sundries | 1.05M | 2.11% | 2.11% | $7.64B | Sep 15, 2025 | ▲ 336.8K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
26
Increased
+3.82M shares3
New Positions
first time holders21
Decreased
−2.71M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.11M
+3.82M / −2.71M
Net new holders
+8
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
NUS insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Nathanson Laura director | May 11, 2026 | Sale | 2,676 | $6.73 | $18.0K | 30.5K | Form 4 ↗ |
WOODBURY EDWINA D director | Mar 11, 2026 | Award | 14 | $7.31 | $102.34 | 43.0K | Form 4 ↗ |
Keisel Justin S EVP, President of Global Sales | Mar 6, 2026 | Award | 47,059 | — | — | 160.2K | Form 4 ↗ |
Hatchett Steven Keith Chief Product Officer | Mar 6, 2026 | Award | 77,941 | — | — | 260.8K | Form 4 ↗ |
Clark Chayce David EVP, COO and CLO | Mar 6, 2026 | Award | 138,971 | — | — | 390.7K | Form 4 ↗ |
Thomas James D Chief Financial Officer | Mar 6, 2026 | Award | 114,706 | — | — | 267.1K | Form 4 ↗ |
NAPIERSKI RYAN S President and CEO | Mar 6, 2026 | Award | 282,353 | — | — | 1.00M | Form 4 ↗ |
Keisel Justin S EVP, President of Global Sales | Feb 26, 2026 | Tax Withhold | 13,687 | $8.63 | $118.1K | 113.1K | Form 4 ↗ |
Hatchett Steven Keith Chief Product Officer | Feb 26, 2026 | Tax Withhold | 26,001 | $8.63 | $224.4K | 182.9K | Form 4 ↗ |
Clark Chayce David EVP and General Counsel | Feb 26, 2026 | Tax Withhold | 45,502 | $8.63 | $392.7K | 251.8K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Nu Skin Enterprises, Inc. (NUS) is primarily owned by institutional investors, who hold approximately 74.8% of total shares outstanding. Company insiders own approximately 2.88%, while retail and public investors account for the remaining 22.30%.
The largest institutional shareholder of Nu Skin Enterprises, Inc. is BLACKROCK, INC., holding approximately 4.53 million shares — equal to 9.11% of outstanding shares — as of March 31, 2025.
A total of 197 institutional investors currently hold NUS stock, with a combined institutional value of approximately $263,705,345 as of the most recent 13F filing period.
Frequently asked questions
NUS ownershipNu Skin Enterprises, Inc. (NUS) is primarily owned by institutional investors, who hold approximately 74.8% of shares. The largest shareholder is BLACKROCK, INC. with a 9.11% stake. Company insiders hold 2.88%. Data sourced from SEC Form 13F as of March 31, 2025.